[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

SE8301609D0 - Forening och komposition for terapeutisk eller diagnostisk anvendning jemte forfarande for terapeutisk behandling - Google Patents

Forening och komposition for terapeutisk eller diagnostisk anvendning jemte forfarande for terapeutisk behandling

Info

Publication number
SE8301609D0
SE8301609D0 SE8301609A SE8301609A SE8301609D0 SE 8301609 D0 SE8301609 D0 SE 8301609D0 SE 8301609 A SE8301609 A SE 8301609A SE 8301609 A SE8301609 A SE 8301609A SE 8301609 D0 SE8301609 D0 SE 8301609D0
Authority
SE
Sweden
Prior art keywords
therapeutic
residue
hydrogen
compounds
association
Prior art date
Application number
SE8301609A
Other languages
English (en)
Original Assignee
Svenska Sockerfabriks Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Publication of SE8301609D0 publication Critical patent/SE8301609D0/sv
Priority to SE8301609A priority Critical patent/SE8301609D0/sv
Application filed by Svenska Sockerfabriks Ab filed Critical Svenska Sockerfabriks Ab
Priority to DE8484850084T priority patent/DE3480288D1/de
Priority to IL71239A priority patent/IL71239A/xx
Priority to AT84850084T priority patent/ATE47595T1/de
Priority to EP84850084A priority patent/EP0126043B1/en
Priority to AU25871/84A priority patent/AU566286B2/en
Priority to DK160484A priority patent/DK160484A/da
Priority to FI841161A priority patent/FI841161A/fi
Priority to JP59053654A priority patent/JPS59176300A/ja
Priority to NO841135A priority patent/NO163656C/no
Priority to IL102589A priority patent/IL102589A0/xx
Priority to IL102584A priority patent/IL102584A0/xx
Priority to IL102583A priority patent/IL102583A0/xx
Priority to IL103012A priority patent/IL103012A0/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54353—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Fats And Perfumes (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
SE8301609A 1983-03-23 1983-03-23 Forening och komposition for terapeutisk eller diagnostisk anvendning jemte forfarande for terapeutisk behandling SE8301609D0 (sv)

Priority Applications (14)

Application Number Priority Date Filing Date Title
SE8301609A SE8301609D0 (sv) 1983-03-23 1983-03-23 Forening och komposition for terapeutisk eller diagnostisk anvendning jemte forfarande for terapeutisk behandling
DE8484850084T DE3480288D1 (en) 1983-03-23 1984-03-14 Carbohydrate derivatives and compositions thereof for therapeutic or diagnostic use
IL71239A IL71239A (en) 1983-03-23 1984-03-14 Pharmaceutical composition containing oligosaccharide derivatives for treatment or prophylaxis of pneumococcus infections
AT84850084T ATE47595T1 (de) 1983-03-23 1984-03-14 Kohlenhydrat-derivate und diese enthaltende zusammensetzungen fuer therapeutische oder diagnostische verwendung.
EP84850084A EP0126043B1 (en) 1983-03-23 1984-03-14 Carbohydrate derivatives and compositions thereof for therapeutic or diagnostic use
AU25871/84A AU566286B2 (en) 1983-03-23 1984-03-19 Compound and composition for therapy or diaenosis
DK160484A DK160484A (da) 1983-03-23 1984-03-20 Terapeutisk eller diagnostisk praeparat
FI841161A FI841161A (fi) 1983-03-23 1984-03-22 Foerening och komposition foer terapeutisk eller diagnostisk anvaendning jaemte foerfarande foer terapeutisk behandling.
NO841135A NO163656C (no) 1983-03-23 1984-03-22 Fremgangsmaate for in vitro diagnostisering av bakterieinfeksjoner fremkalt av pneumokokker samt forbindelser for anvendelse ved fremgangsmaaten.
JP59053654A JPS59176300A (ja) 1983-03-23 1984-03-22 治療または診断上有用な化合物および組成物
IL102589A IL102589A0 (en) 1983-03-23 1992-07-21 Oligosaccharide derivative
IL102584A IL102584A0 (en) 1983-03-23 1992-07-21 Oligosaccharide derivative
IL102583A IL102583A0 (en) 1983-03-23 1992-07-21 Oligosaccharide derivative
IL103012A IL103012A0 (en) 1983-03-23 1992-09-01 Pharmaceutical and diagnostic compositions containing oligosaccharide derivatives coupled to a macromolecular carrier

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8301609A SE8301609D0 (sv) 1983-03-23 1983-03-23 Forening och komposition for terapeutisk eller diagnostisk anvendning jemte forfarande for terapeutisk behandling

Publications (1)

Publication Number Publication Date
SE8301609D0 true SE8301609D0 (sv) 1983-03-23

Family

ID=20350499

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8301609A SE8301609D0 (sv) 1983-03-23 1983-03-23 Forening och komposition for terapeutisk eller diagnostisk anvendning jemte forfarande for terapeutisk behandling

Country Status (10)

Country Link
EP (1) EP0126043B1 (sv)
JP (1) JPS59176300A (sv)
AT (1) ATE47595T1 (sv)
AU (1) AU566286B2 (sv)
DE (1) DE3480288D1 (sv)
DK (1) DK160484A (sv)
FI (1) FI841161A (sv)
IL (1) IL71239A (sv)
NO (1) NO163656C (sv)
SE (1) SE8301609D0 (sv)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2564468B1 (fr) * 1984-05-16 1994-12-23 Choay Sa Nouveaux oligosaccharides, leur preparation par voie de synthese et leurs applications biologiques
DK17685D0 (da) * 1985-01-14 1985-01-14 Hans Goeran Magnusson Glycosidderivater
SE8501613D0 (sv) * 1985-04-01 1985-04-01 Bio Carb Ab Foreningar for terapeutisk eller diagnostisk anvendning jemte forfarande for terapeutisk behandling
EP0287029A2 (de) * 1987-04-14 1988-10-19 Pulverer, Gerhard, Prof. Dr.Dr.h.c. Verwendung von Monosacchariden und/oder diese Monosaccharide enthaltenden Glykokonjugaten zur Behandlung von Infektionen durch Krankheitserreger
SE463314B (sv) * 1989-03-01 1990-11-05 Biocarb Ab Sampolymerer av en n-acylerad glykosylamin och en amid, n-akryloyl-eller metakryloylglykosylaminer samt foerfarande foer framstaellning av dessa
ES2127198T3 (es) * 1990-08-02 1999-04-16 Antex Biolog Inc Receptores de adhesion para microorganismos patogenos u oportunistas.
US5718909A (en) * 1991-02-18 1998-02-17 Medscand Ab Sheet containing carbohydrate derivative for removal of E. coli
SE469256B (sv) * 1991-02-18 1993-06-14 Medscand Ab Rengoeringsprodukt
DE69319771T2 (de) * 1992-03-31 1999-04-22 Dai Nippon Printing Co., Ltd., Tokio/Tokyo Immobilisierte Enzym-Elektrode, Zusammensetzung zu ihrer Herstellung und elektrisch leitfähige Enzyme
US5401723A (en) * 1992-12-02 1995-03-28 Colgate-Palmolive Company Glycoconjugate inhibition of Streptococcus pyrogenes adhesion
US5514665A (en) * 1993-12-30 1996-05-07 University Of British Columbia Method of preventing or reducing the risk of infection by bacterial pathogens utilizing simple and conjugated dextrans
US5665561A (en) * 1994-06-06 1997-09-09 The Rockefeller University Modulators of pneumococcal adherence to pulmonary and vascular cells and diagnostic and therapeutic applications
US5736533A (en) * 1995-06-07 1998-04-07 Neose Technologies, Inc. Bacterial inhibition with an oligosaccharide compound
US6737524B2 (en) 2002-03-25 2004-05-18 Paul K. Smith Activated polyethylene glycol compounds
US7144989B2 (en) 2002-03-25 2006-12-05 Albert Einstein College Of Medicine Of Yeshiva University Pegylated non-hypertensive hemoglobins, methods of preparing same, and uses thereof
EP1629850B2 (en) 2004-08-24 2013-05-22 N.V. Nutricia Nutritional composition comprising indigestible transgalactooligosaccharides and digestible galactose saccharides

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4324887A (en) * 1978-08-16 1982-04-13 President And Fellows Of Harvard College Type II group B Streptococci polysaccharide
SE8000658L (sv) * 1980-01-28 1981-07-29 Sigfried Edvin Svensson Isolering av kolhydrater ur cellvevnad
SE8001748L (sv) * 1980-03-05 1981-09-06 Kaellenius Gunilla Kompositioner for terapeutisk eller diagnostisk anvendning jemte forfarande for terapeutik
WO1981003175A1 (en) * 1980-05-09 1981-11-12 H Leffler Carbohydrate derivatives for inhibiting bacterial adherence
AU561066B2 (en) * 1982-03-22 1987-04-30 Biocarb Ab Antibacterial composition containing an oligosaccharide
EP0089940A1 (en) * 1982-03-23 1983-09-28 BioCarp AB Compositions for therapeutic or diagnostic use containing oligosaccharides

Also Published As

Publication number Publication date
AU2587184A (en) 1984-09-27
IL71239A (en) 1993-05-13
NO841135L (no) 1984-09-24
FI841161A0 (fi) 1984-03-22
EP0126043B1 (en) 1989-10-25
IL71239A0 (en) 1984-06-29
ATE47595T1 (de) 1989-11-15
NO163656B (no) 1990-03-19
EP0126043A1 (en) 1984-11-21
DK160484A (da) 1984-09-24
NO163656C (no) 1990-06-27
AU566286B2 (en) 1987-10-15
FI841161A (fi) 1984-09-24
JPS59176300A (ja) 1984-10-05
DE3480288D1 (en) 1989-11-30
DK160484D0 (da) 1984-03-20

Similar Documents

Publication Publication Date Title
SE8301609D0 (sv) Forening och komposition for terapeutisk eller diagnostisk anvendning jemte forfarande for terapeutisk behandling
AR002240A1 (es) Derivado de 2,4-oxazolidinadiona, composicion farmaceutica que lo comprende y metodo de preparacion del mismo.
PT87552A (pt) Process for the preparation of novel tetrazole intermediates toantihypertensive compounds
DE3881246D1 (de) Durch benzhydryl n-substituierte heterocyclische derivate, ihre herstellung und ihre verwendung.
FI901530A0 (sv) Förfarande för framställning av immunomodulerande azaspiraner
ATE139783T1 (de) Azasteroide zur behandlung prostatischer hypertrophie, ihre herstellung und verwendung
FI830958L (fi) Kompositioner foer terapeutisk eller diagnostisk anvaendning och foerfarande foer terapeutisk behandling
FR2662701B1 (fr) Composition tinctoriale a base de 5,6-dihydroxyindolines et procede de teinture des fibres keratiniques.
KR840004761A (ko) N-글리코실화 카복스아미드 유도체의 제조방법
BG101402A (en) Apoliprotein-b synthesis inhibitors
ATE59646T1 (de) 4-brommethyl-5-methyl-1,3-dioxolen-2 -on und verfahren zu seiner herstellung.
SE8304006D0 (sv) Forening och komposition for terapeutisk eller diagnostisk anvendning samt forfarande for terapeutisk behandling
ATE67199T1 (de) Benzoxazin-derivate und verfahren zu ihrer herstellung.
FR2623808B1 (fr) Nouveaux derives flavonoides (benzyl-4 piperazinyl-1)-2 oxo-2 ethylene substitues, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
PT78942B (fr) Procede de preparation de nouveaux derives de l'acide 4-phenyl 4-oxo buten-2-oique
SE8406626D0 (sv) Forening och komposition for terapeutisk eller diagnostisk anvendning jemte anvendning av sadan forening och komposition for terapeutisk behandling och isolering av shigatoxin
ATE69448T1 (de) Chinolincarbonsaeure-derivate, diese enthaltende zusammensetzung, verfahren zu ihrer herstellung und ihre verwendung zur herstellung von medikamenten.
FI910059A0 (fi) Kemiska foereningar.
DE3775526D1 (de) Bakterizide pyridobenzothiazinderivate mit langer wirkungsdauer.
ES2054829T3 (es) Antibioticos del grupo mureidomicina, su preparacion y su empleo.
NO810778L (no) Homositronsyre oligoriboside-derivater, fremgangsmaate for deres fremstilling og deres bruk for aa forebygge dental karries
ATE27698T1 (de) 1-(aminophenyl)-2-amino-ethanon-derivate, verfahren zur herstellung und therapeutische verwendung.
TH10969EX (th) อนุพันธ์เบนซิไซไธโออะโวลิโนน-1-ไดออกไซด์ในรูปสารยับยั้งเอนไซม์อีลาสเทส